{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-066956","form_type":"8-K","ticker":"PASG","cik":"0001787297","company_name":"Passage BIO, Inc.","filed_at":"2026-05-27T20:15:26+00:00","discovered_at":"2026-05-27T20:17:00.415435+00:00","generated_at":"2026-05-27T20:21:19.798834+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Passage Bio terminates Gemma collaboration and exits Philadelphia office lease with $2.3M fee","bullets":["Terminated Gemma Biotherapeutics collaboration covering Huntington's disease and Temporal Lobe Epilepsy programs, effective May 21, 2026.","Termination also eliminates options for four new CNS indications under the July 2024 agreement.","Paid $2.3M to exit 37,000 sq ft office lease (originally expiring Dec 2031); company is remote-only.","Subleases previously covered substantially all of that office space."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-066956","json":"https://secwatch.observer/filing/0001104659-26-066956.json","markdown":"https://secwatch.observer/filing/0001104659-26-066956.md","text":"https://secwatch.observer/filing/0001104659-26-066956.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787297/000110465926066956/0001104659-26-066956-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787297/000110465926066956/pasg-20260521x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T20:21:19.798834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001379785-26-000024","ticker":"BBDC","company_name":"Barings BDC, Inc.","filed_at":"2026-06-01T20:15:45+00:00","headline":"Barings BDC receives $67M cash from adviser, enters new $11M credit support for Sierra legacy investments","event_type":"other_material","sec_items":["1.01","1.02","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001379785-26-000024","json":"https://secwatch.observer/filing/0001379785-26-000024.json","markdown":"https://secwatch.observer/filing/0001379785-26-000024.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1379785/000137978526000024/0001379785-26-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1379785/000137978526000024/bbdc-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-249684","ticker":"INAB","company_name":"IN8BIO, INC.","filed_at":"2026-06-01T10:56:36+00:00","headline":"IN8bio enters new ATM equity facility with JonesTrading, terminates prior Cantor agreement","event_type":"other_material","sec_items":["1.01","1.02","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249684","json":"https://secwatch.observer/filing/0001193125-26-249684.json","markdown":"https://secwatch.observer/filing/0001193125-26-249684.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1740279/000119312526249684/0001193125-26-249684-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1740279/000119312526249684/d100941d8k.htm"},"side_by_side_evidence":null},{"accession":"0001214659-26-006815","ticker":"GPUS","company_name":"Hyperscale Data, Inc.","filed_at":"2026-05-28T10:45:23+00:00","headline":"Hyperscale Data terminates ATM sales agreement after raising $24.7M at $0.1793/share","event_type":"other_material","sec_items":["1.02","7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-26-006815","json":"https://secwatch.observer/filing/0001214659-26-006815.json","markdown":"https://secwatch.observer/filing/0001214659-26-006815.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/896493/000121465926006815/0001214659-26-006815-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896493/000121465926006815/g5272608k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-025336","ticker":"HCWB","company_name":"HCW Biologics Inc.","filed_at":"2026-05-27T12:00:25+00:00","headline":"HCW Biologics terminates Wugen license, regains ex vivo rights to HCW9201/9206 at no cost","event_type":"other_material","sec_items":["1.02","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025336","json":"https://secwatch.observer/filing/0001493152-26-025336.json","markdown":"https://secwatch.observer/filing/0001493152-26-025336.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226025336/0001493152-26-025336-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226025336/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-036943","ticker":"BRCB","company_name":"Black Rock Coffee Bar, Inc.","filed_at":"2026-05-20T20:40:08+00:00","headline":"Black Rock Coffee Bar secures irrevocable proxy over founder shares; terminates Cynosure voting agreement","event_type":"other_material","sec_items":["1.01","1.02","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-036943","json":"https://secwatch.observer/filing/0001628280-26-036943.json","markdown":"https://secwatch.observer/filing/0001628280-26-036943.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2068577/000162828026036943/0001628280-26-036943-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2068577/000162828026036943/brcb-20260515.htm"},"side_by_side_evidence":null},{"accession":"0001766478-26-000038","ticker":"AOMR","company_name":"Angel Oak Mortgage REIT, Inc.","filed_at":"2026-05-20T20:31:17+00:00","headline":"Angel Oak Mortgage REIT to repurchase $15M of stock from Xylem; board member resigns","event_type":"other_material","sec_items":["1.01","1.02","5.02","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001766478-26-000038","json":"https://secwatch.observer/filing/0001766478-26-000038.json","markdown":"https://secwatch.observer/filing/0001766478-26-000038.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766478/000176647826000038/0001766478-26-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766478/000176647826000038/aomr-20260519.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-231482","ticker":"EVC","company_name":"ENTRAVISION COMMUNICATIONS CORP","filed_at":"2026-05-20T01:09:48+00:00","headline":"Entravision and Alexandra Seros mutual terminate cooperation agreement; Strickler stays on board","event_type":"other_material","sec_items":["1.02","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-231482","json":"https://secwatch.observer/filing/0001193125-26-231482.json","markdown":"https://secwatch.observer/filing/0001193125-26-231482.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1109116/000119312526231482/0001193125-26-231482-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1109116/000119312526231482/evc-20260518.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-229089","ticker":"SLN","company_name":"Silence Therapeutics plc","filed_at":"2026-05-18T21:00:15+00:00","headline":"Silence Therapeutics enters new ATM with Jefferies; says not PFIC for 2025","event_type":"other_material","sec_items":["1.01","1.02","8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-229089","json":"https://secwatch.observer/filing/0001193125-26-229089.json","markdown":"https://secwatch.observer/filing/0001193125-26-229089.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479615/000119312526229089/0001193125-26-229089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479615/000119312526229089/sln-20260518.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}